PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Acquires Worldwide License for Herbal Sleep Aids
Millions worldwide affected by sleep disorders Sleep disorder market set to exceed $50 billion by 2020 New marketing initiative kicks off with engagement of IR firm Updated Crystal Equity Research report now available Counting sheep may soon be a thing of the past, for PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has been awarded a worldwide license to manufacture, distribute and market three Health Canada-approved sleep aids (http://cnw.fm/K2s5q). This milestone could not have come at a better time. Sleeping disorders affect around 40 percent of adults in Canada (approximately 15 million), according to a study conducted at the Université…